Data Driven Approach in Clinical Trials

According to NCBI, ~80% of clinical trials fail to meet initial enrolment target, resulting in significant delays and sunk revenues of ~US $8 Million/day for pharma and biotech companies. Patient recruitment/retention, accurate patient mapping is the #1 challenge in clinical trials.

Discover how a data-driven approach can address such challenges in Finarb’s upcoming session.

Case study discussion: on Sep 28, 9:30 AM PST, join IQVIA, Finarb, Greenphire and Frazier Lifesciences as we delve into industry case studies and explore how enterprises can adopt a data-driven approach and custom AI to advance clinical trials at various stages.

Get your queries addressed about how to get the most out of your data & AI initiatives for clinical trials.

Our speakers:
JINU JOSE
IQVIA – VP of Clinical Data Management

KEN MCLAREN
FRAZIER HEALTHCARE – Partner for Data & AI

ABHISHEK RAY
FINARB ANALYTICS – Chief of Data Science

Agenda:

-Introduction by Finarb
-Insights into the CRO/Pharmaceuticals survey
-IQVIA-How AI ML-driven data management is accelerating clinical trial processes
-Finarb’s AI use cases in trial design, patient recruitment & retention, controlling dropouts
-How Frazier LifeSciences portfolio CRO’s are applying AI in clinical trials
-Audience Q&A